TXMD

Therapeuticsmd Inc

2.140

+0.030+1.42%

Closed16:16 05/29 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.030/1.970

TODAY RANGE1.980-2.070

VOL10.58K

MARKET CAP22.92M

52 WEEK RANGE0.9811-2.950

AVG VOL (3M)23.93K

% TURNOVER0.09%

TURNOVER--

P/E (TTM)128.57

% RANGE4.58%

EPS(TTM)0.0154

P/E(FORWARD)12.38

P/B0.8496

BVPS2.331

DIVIDEND--

P/S7.58

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP21.21M

SHARES OUTSTANDING11.57M

NEXT EARNINGS08/10-08/14

FREE FLOAT10.71M

LOT SIZE1

EX-DATE05/09/2022

News

Press Releases

Financial Reports

Profile

Benzinga·05/12 21:47
TherapeuticsMD Says Company Continues To Evaluate Strategic Alternatives, Including Acquisition Or Merger
TipRanks·05/12 20:47
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
Seeking Alpha·05/12 20:24
Therapeutics MD reports Q1 results
Reuters·05/12 20:13
TherapeuticsMD swings to Q1 net income as license revenue rises
PUBT·05/12 20:08
TherapeuticsMD swings to FY26 Q1 profit of $103,000; revenue rises 84.2% to $724,000
Reuters·05/12 20:05
THERAPEUTICSMD INC - COMPANY CONTINUES TO EVALUATE STRATEGIC ALTERNATIVES INCLUDING ACQUISITION OR MERGER
Dow Jones·04/27 20:33
TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market
Dow Jones·04/06 20:32
TherapeuticsMD Inc. Stock Rallies 10.0%, Outperforms Market
TipRanks·04/01 15:39
TherapeuticsMD Explains Brief Delay In Annual Filing
Reuters·04/01 10:08
TherapeuticsMD delays 2025 10-K after filing omits auditor report
TipRanks·03/31 00:12
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
Benzinga·03/30 22:10
TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY
Dow Jones·03/30 20:34
TherapeuticsMD Inc. Stock Slides 5.2%, Underperforms Market
TipRanks·03/30 20:23
TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year
Seeking Alpha·03/30 20:15
Therapeutics MD reports FY results

Same Industry

Name/Symbol

Change%

Price

Therapeuticsmd Inc

TXMD

+1.42%

2.140

MCK

BIIB

AMGN

SHPG

CELG-RT

Celgene

CELG

0.00%

108.24

Lilly Eli & Co

LLY

-1.93%

Johnson & Johnson

JNJ

+0.60%

224.24

Abbvie Inc

ABBV

-0.42%

217.72

Zoetis Inc

ZTS

+1.97%

77.90

Gilead Sciences Inc

GILD

-1.31%

134.43

Novo-Nordisk A/S

NVO

+0.15%

45.58

Bristol-Myers Squibb Co

BMY

-0.89%

54.46

ALXN

Pfizer

PFE

+0.15%

26.18

Sanofi FR

SNY

-1.40%

43.67

GCVRZ

NVS

Dr Reddys Labs

RDY

-1.73%

13.03

GSK PLC

GSK

+1.07%

49.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.